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Abstract 
The Sir2 (Silent Information Regulator 2) encoded protein (Sir2) in yeast is a 
nicotinamide adenine dinucleotide (NAD+) – dependent histone deacetylase. A 
mechanistic explanation has been proposed whereby Sir2 is able to slow aging in yeast 
cells. Here, our experiment is focused on the effects of the Sir2 gene on the mutation 
frequency in mitochondrial DNA. It is believed that mutations in mitochondrial DNA 
(mtDNA) will cause aging by damaging the electron transport chain. In this 
experiment, five different yeast strains were used respresenting: Wild type, a Sir2-over 
expressing strain, a Sir2 deletion strain, an ogg1 deletion strain (positive control), and 
a strain with the pYES2 plasmid without Sir2 incorporated. All strains weree plated on 
N3E (containing glycerol and erythromycin) plates in order to find the effect of Sir2 on 
mtDNA mutation frequency. The experimental results showed that over-expression of 
Sir2 effectively reduced the mutation frequency whereas the absence of Sir2 increased 
the mutation frequency. However, different sorts of errors may have occurred during 
the experiment; thus, further experiments are needed to verify the results. 
 - 3 - 
Abbreviations 
 
ADP: Adenosine Di-Phosphate 
ATP: Adenosine Tri-Phosphate 
BER: Base Excision Repair 
CR: Calorie Restriction 
ERC: Extrachromosomal rDNA Circle 
HDAT: Histone deacetylase 
mtDNA: Mitochondrial DNA 
NAD: Nicotinamide Adenine Dinucleotide 
NADPH: Nicotinamide aAdenine Dinucleotide Phosphate-Oxidase 
NAM: nicotinamide 
OAADPr:O-acetyl-ADP-ribose 
OD: Optical Density 
OGG1: 8-Oxo-G-Glycosylase 
PCR: Polymerase Chain Reaction 
ROS: Reactive Oxygen Species 
rRNA: Ribosomal RNA 
SIR2: Silent Information Regulator-2 
SIRT1: Silent Information Regulator Two 1 
URA: Uracil 
WT: Wild Type 
YPD: Yeast extract, Peptone, Dextrose 
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1 Introduction 
1.1 Ageing 
Aging is a process that is manifested by a progressive decline in vitality over time 
leading to death. Yet, the details and processes that cause human ageing are still not 
clear. However, recent research of the Sir2 or "Silent Information Regulator 2" gene in 
yeast shows that it can extend the lifespan of yeast. This effect is achieved partially by 
reducing the levels of toxic rDNA circles in aged mother cells. [1] However, the 
longevity function of the Sir2 gene has been found to be associated with other factors 
other than stabilizing the rDNA. Evidence states that expression of Sir2 in C. elegans 
will increase the life span and deletion of Sir2 will shorten the life span. Detailed 
reasons are still under investigated. [2] However, it is not by reducing toxic rDNA. 
Recent research also shows that there are different ways that Sir2 gene could influence 
the life span of yeast, including a connection with Caloric Restriction. [3] These 
studies have led to the general conclusion that deletions of Sir2 shorten lifespan of 
yeast and an extra copy of this gene increases the life span. [4] 
 
 
1.2 Caloric Restriction (CR) 
It has been proved that caloric restriction slows ageing and increases lifespan in many 
organisms. [5] And it is generally known that CR leads to activation of Sir2 (the 
protein encoded by Sir2 in yeast) which has a function to slow the ageing in the cell. 
However, this theory is challenged recently by different views. One of them suggests 
that identification of a Sir2-independent pathway responsible for a majority of the 
longevity benefit associated with CR. [6]  
With all the theories stated above there is no doubt that CR has a positive effect to 
increase the lifespan, despite the different ways that CR works. 
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1.3 Reactive Oxygen Species (ROS) 
Reactive oxygen species (ROS) refer to oxygen ions, free radicals, and peroxides, both 
inorganic and organic and can be produced from both endogenous and exogenous 
sources. [7] They are very reactive due to the presence of unpaired valence shell 
electrons, and are normally formed as a by-product of metabolism. ROS are normally 
considered to have a negative effect, shortening age; the obvious reason is that aged 
cells may have gone through many periods of environmental stress in which the levels 
of ROS may increase dramatically. This may have damaged the DNA and caused the 
oxidation of the amino acid etc., leading to cell malfunctioning and eventually cell 
death. Therefore preventing the accumulation of ROS might be a way of slowing 
ageing. 
Accumulation of mutations in the cells can also reduce the lifespan since most 
mutations have negative effects on the cell. So the mutation in mtDNA will cause 
aging as well. 
In this project will try to establish whether there is a link between Sir2-expression and 
yeast mitochondrial DNA mutation frequency. 
1.4 SirT1 the Ortholog of Sir2 
In mammals, Sirt1 is generally considered as the ortholog of the Sir2 gene. It has the 
ability to regulate the fat mobilization, fatty acid oxidation, glucose production, and 
insulin secretion in response to nutrient availability. [8] Due to that fact, we thought it 
would also be interesting to investigate if the human SirT1 gene can have the same 
effect on mtDNA mutation frequency of yeast mother cell as the yeast Sir2 does. 
However, although we designed and attempted the SirT1 based experiment; yet, due to 
the difficulty of PCR-amplifying the Sirt1 gene, we finally gave up the idea and 
focused on the Sir2 gene. But it will be important to extend the link between Sir2 gene 
and longevity to mammals. Assuming mammalian Sir2 (SirT1) genes do regulate 
longevity, determining their function could well identify those processes that limit 
lifespan in mammals. 
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2 Problem formulation 
 
Despite the specific way of how the Sir2 gene increases the aging of yeast mother cells 
are still not known, we are particularly interested in the effect of Sir2 on the 
mitochondrial DNA mutation frequency, since accumulation of mitochondrial 
mutations are considered to be underlying the age-related decline in cellular function 
and viability. 
Thus we wish to investigate whether some of the longevity effect of Sir2 could perhaps 
be mediated by a reduced mitochondria DNA mutation frequency.  
Therefore our problem formulation is:  
 
Does Sir2 expression influence the mitochondrial DNA 
mutation frequency in yeast? 
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3 Theory  
 
3.1 Mitochondria 
Mitochondria are organelles with double membranes which are present in most 
eukaryotic cells; the number of mitochondria in cells varies with the cell’s specific 
function and energy that the cells need. The mitochondrion is known as the cell’s 
powerhouse, in which the chemical enegy stored in adenosine triphosphate (ATP) are 
produced through metabolizing carbohydrates, fat and amino acids. Under aerobic 
condition, one molecule of glucose leads to the production of 34 ATP´s via respiration 
in mitochondria.  
 
The mitochondrion has its own circular DNA (mtDNA), which encodes 13 mRNAs, 22 
tRNAs and 2 rRNAs. The translated 13 proteins are the key components in the 
respiratory chain. [11] 
 
Comparing with nuclear DNA (nDNA), mtDNA usually has a higher mutation 
frequency. Following reasons are considered. Firstly, there are no introns in 
mitochondrial genes or protective protein histones wrapped around mtDNA, these two 
factors facilitates damaging attacks by mutagens. [12] Additionally, there are multiple 
copies of mtDNAs in the cell which may choose to degrade or rule out the damaged 
molecule rather than repair it during replication. Furthermore, according to recent 
research, only base excision repair (BER) and recombination repair system are found in 
the mitochondria of higher eukaryotes, while the nucleotide excision repair (NER), 
which responses to UV damage, and is not present in mitochondria. [13] [14] what is 
more, the respiratory chain is closer to mtDNA than nDNA, so the ROS leaking from 
the electron transport chain could damage mtDNA more severly. 
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Mitochondrial DNA is therefore susceptible to reactive oxygen species (ROS), such as 
hydrogen peroxide (H2O2), superoxide radicals (O2·-) and hydroxyl radicals (·OH). 
ROS can generate various DNA base modifications, for example, the formation of 
thymidine glycol and 8-oxo-7-hydrodeoxyguanosine (8-oxo dG). Generally, 
oxidatively damaged bases caused by ROS can be repaired via the base excision repair 
system. This is carried out by DNA glycosylases which recognize the damaged base 
and cleave the base-sugar bonds, generating apurinic or apyrimidinic (AP) sites. Then 
an AP endonuclease nicks the damaged strand upstream of the AP site, and a stretch of 
neighboring sugar-phosphate residue is removed by deoxyribophosphodiesterase. In 
succession, DNA polymerase synthesizes a new DNA strand of which the nucleotides 
are complementary to the other strand. At last, the nick is sealed by DNA ligase which 
catalyzes the formation of a phosphodiester bond between the 5’-phosphate end and 
the adjacent 3’-OH group. [15]  
 
Dysfunction in mitochondria could cause maternally inherited diseases; moreover, it is a 
major source leading to aging. By recently research, mitochondria regulate aging 
through at least four processes: energy production, generation of ROS, apoptosis and 
metabolism. [16]  
 
Recent research shows that loss of mitochondrial function is a major inducible factor 
in aging. MtDNA polymerase (Pol-γ) is the only polymerase present in mitochondria; 
a specific mutation in the gene encoding wild-type Pol-γ can lead to an error-prone 
Pol-γ, which leads to accumulation of mitochondrial mutations. 
Therefore increased mitochondrial resistance to ROS damage and/or reduced mtDNA 
mutation frequency can extend lifespan. [17]  
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3.2 Histone damage related to increased mtDNA mutation 
frequency 
The histone modification acetylation has a significant effect on the gene expression. 
Evidence has shown that histones associated with the nucleosomes of active genes are 
rich in acetyl groups; however, inactive genes are underacetylated. [18] In yeast, 
GCN5 is found as a histone acetyltransferase, it binds to the DNA in the regulatory 
regions and activates transcription by acetylating nearby histones. On the other hand 
this process is reversible. Histone deacetylase (HDAT) is the key regulatory factor of 
the reversed process. 
 
HDAC catalyzes deacetylation of acetylated lysine residues on histones and a growing 
number of nonhistone proteins including many transcription factors. For example 
Sirtuins (the Sir2-like proteins) can be sorted into 4 different classes. Class I and Class 
II are Zinc dependent and Class III are NAD+ dependent [19]  
 
The class III enzymes are also a part of enzymes that constitute the HDACs. Class III 
HDACs catalyze the NAD+ dependent deacetylation of acetylated lysine residues in 
target proteins resulting in the formation of deacetylated protein, O-acetyl-ADP-ribose 
(OAADPr) and nicotinamide (NAM) [20]  
 
The conclusion of Histone acetylation and deacetylation is that they are both important 
factors which can regulate the gene expressions, by the way of promoting and 
repressing gene transcription, respectively. This leads to the question if the Sir2 
mediated deacetylation of histone in nuclear DNA will affect the mutation frequency 
in mtDNA?  
 
The nuclear DNA encodes most of the proteins of the electron transport chain, so 
Sir2-mediated regulation of nuclear genes may in turn affect the number of active 
electron transport chains in mitochondria. This may in turn influence the ROS 
production and consequently the mitochondrial DNA mutation frequency. 
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3.3 NAD and the regulation of Sir2 activity 
As mentioned, Sir2 or Sirtuins as a part of class III HDACs can mediate the histone 
deacetylation under the presence of NAD+. [21] But the activity of Sir2 and its 
homolog is also regulated by the metabolism of NAD+. 
 
Recent research states that the changes in NAD+ metabolism can regulate the activity 
of the Sir2 and its homologs. It has been said the deletion of NPT1 which encodes a 
recycling enzyme (nicotinate phosphoribosyltransferase) in the yeast NAD+ 
biosynthetic pathway will cause a decrease in Sir2 activity. It is determined by a loss of 
Sir2p-dependent extended longevity. [22] In the yeast NAD+ pathway (Illustrated by 
the figure 1 below) the Sir2 enzyme and its homologs can convert NAD+ to 
nicotinamide. Nicotinamide is an endogenous inhibitor of Sir2 functions. 
Nicotinamide recycling is dependent on the activity of pnc1. Evidence shows that this 
nicotinamidase can regulate nicotinamide concentrations in cells, thereby regulating 
Sir2 catalytic function 
 
Fig.1 
NAD+ metabolism in yeast. Genes for nmnat and pnc1 when deleted or 
overexpressed provide changes in Sir2 biological functions (silencing and 
longevity). [23] 
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3.4 Mitochondria and the SIR2 gene 
Mitochondria cell plays a significant role in aging. Recently, many researches found 
that calorie restriction can increase the mitochondrial activity involving in some 
regulatory factors, such as Sir2 gene in yeast and its homologous gene SirT1 in 
mammalians. [24] 
 
Researchers suggested that CR can extend life span through decreasing the rate of 
respiration and damages produced by ROS. [25]  
In yeast, the protein encoded by Sir2 gene has a kind of enzymatic activity, it is a 
NAD-dependent deacetylase. Sir2 deacetylates histones, leading to silencing of a block 
of chromatin in the genome. This enzymatic activity can also recruit some related 
proteins to take part in the metabolism, due to the central reaction of NAD and NADH. 
So Sir2 proteins become regulators for extending the life span by CR. [25] There are 
two possible pathways have been shown to activate the Sir2 in respond to CR in yeast: 
Firstly, CR increases the respiration and lead to an increase in NAD/NADH ratio in 
cells. NADH was an inhibitor or repressor of the enzyme. Because of the decrease in 
NADH level, the Sir2 gene can be activated. In another pathway, CR can increase the 
activity of a nicotinamidase. Nicotinamide is also an inhibitor of the Sir2 protein; this 
will increase the enzymatic activity. [25] 
 
In our report, we need to find if the Sir2 gene can reduce the number of mitochondria 
mutations which are primarily caused by ROS. So understanding the regulation of 
ROS in mitochondria is necessary. 
 
3.5 Mitochondrial regulation of ROS: 
The long-lived species can produce high levels of antioxidant enzymes and CR can 
lead to a decline of ROS products. In fact, most ROS are produced by complexes I 
(NADH dehydrogenase) and III (cytochrome b-c complex) in the electron transport 
chain. [26] Stalling the electrons in these complexes can cause a high ROS level in the 
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cells. The following picture illustrates two pathways that cause high level ROS and 
low level of ROS respectively.  
If the electron transport through complex IV were limiting, that will increase the rate of 
entry of electrons into complex I and trigger the electron stalling at the complex I and 
III. Thus the ROS levels become high. 
During the CR, the number of electron transport chains increase, thereby decreasing 
the entry of electrons per ETC. CR also increase the fraction of electrons that bypass 
complex I by entering the ETC through the electron transfer ETF (flavoprotein 
dehydrogenase). These factors result in reducing the production of ROS. [24]   
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4 Experimental Strategy 
 
4.1 Over-expression 
It is often desirable to manipulate cells to produce a massive quantity of a particular 
protein ("overexpress the gene" = "overproduce the protein") for biochemical studies 
or for commercial purposes. In this case, it is the Sir2 encoding protein we are 
interested in. To test whether the Sir2 gene affects mutation frequency of 
mitochondrial DNA, over-expression is needed for the comparison with wild type 
levels as well as with no Sir2 production. (Details see contrastive groups). 
For over-expression studies, first a proper vector must be chosen – the pYES2 plasmid 
which can multiply in E. coli as well as in yeast and expression of the cloned gene can 
be induced in yeast by induction with galactose. 
 
The Sir2 gene is PCR-amplified from yeast genomic DNA while the human SirT2 is 
attempted to be PCR-amplified from a human cDNA library. In both cases the primers 
used include restriction sites which can be used to clone in the cloning site of pYES2. 
 
Both the Sir2 PCR-fragment and the pYES2-vector are digested and mixed; by chance, 
some Sir2 gene would insert into pYES2 plasmid. After ligation, pYES2 plasmid 
containing Sir2 gene would be transferred to host cell (details see Sir2 and 
mitochondria). Now, a cell that contains an endogenous Sir2 gene as well as a 
galactose-inducible Sir2 gene is generated, and Sir2-over-expression can therefore be 
obtained. 
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4.2 Contrastive groups  
In our experiment, we used three types of strains from a yeast deletion library: a wild 
type (YO) strain, a Sir2 deletion strain, and an Ogg1 deletion strain.  
 
Besides these, we also use two kinds of yeast transformants: both were made by 
transforming the wild type YO strain, one is derived from transforming with the empty 
pYES2 plamid, the other was made using the pYES2-Sir2 plasmid  
 
There are three contrastive groups; the first group is composed of wild type (wt), Sir2 
deletion cells (Sir2-) and Sir2 over expressed cells (pYES2-Sir2). By making this assay, 
we would like to know whether the Sir2 gene has an effect on yeast mitochondrial 
DNA (mt-DNA) mutation frequency and if yes, then whether the effect is positive; that 
the expressed Sir2 gene reduces the mt-DNA mutation frequency or negative; that Sir2 
increases the mutation frequency instead. From data analysis, we probably could find 
out what is the extent of mutation frequency raised/reduced by the Sir2 gene 
expression. 
 
The second comparable group involves the wt cells and two sorts of transformants with 
pYES2 and pYES2-Sir2, respectively. This is to make sure the influences on mt-DNA 
mutation frequency are not caused by the transformation of pYES2 vectors but the Sir2 
gene which is incorporated into the vector. 
 
In the last group we use the Ogg1 deletion strain as a positive control. As we 
mentioned before, the ROS produced in mitochondria could cause base modifications 
which lead to a lesion in DNA, the most common and abundant mutation is the 
8-oxo-7-hydrodeoxyguanosine (8-oxo dG), which then mispairs with adenine in 
replication, resulting in a C·G → A·T transversion. (Depicted in Fig.2) [27]  
 
As mentioned, the yeast Ogg1 gene encodes a DNA glycosylase that repairs oxidized 
guanines in DNA through base excision repair (BER). What is more, the Ogg1 protein 
recognizes 8-oxo dG opposite cytosine and thus catalyzes the excision of 8-oxo dG, but 
 - 17 - 
it is poorly functioning when 8-oxo dG is opposite adenine or guanine. [28]  
 
After excising and releasing the oxidative damaged 8-oxo dG base by the Ogg1 protein, 
the correct bases are inserted which are guided by the complementary bases in the 
other undamaged strand and operated by multiple proteins such as polymerase, ligase, 
etc. 
 
 
Fig.2 A) Oxidation of guanosine by reactive oxygen species (ROS) leads to the 
formation of 8-oxo dG, which is distinguished from guanosine by the O8 group 
(colored red) and the protonation of nitrogen N7 (colored blue). Guanosine 
predominates in an anti conformation whereas the syn conformation is favored in 
8-oxo dG. B) 8-oxo dG pairing with cytosine in the anti conformation (left) and 
pairing with adenine in the syn conformation (right) [29] 
 
When the yeast Ogg1 gene is deleted, the 8-oxo dG can not be recognized and repaired, 
as a result, the bulky mispairs take place in the replication which leads to an increase in 
mt-DNA mutation frequency. 
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4.3 Erythromycin and N3 plates 
 
Fig. 3 
The chemical structure of erythromycin [30] 
Erythromycin (see Figure 3) is utilized as an antibiotic to select against wild types in 
our experiment. However, mutants’ mitochondrial rRNAs are not bound by 
erythromycin and are therefore immune to it (details see how to select by 
erythromycin). By doing so, erythromycin binds to erythromycin-binding site on the 
23S rRNA of the 50S ribosomal subunit in mitochondria and interferes with the 
peptidyl transferase activity. [31] Since the translation in mitochondrial rRNA is 
blocked, the protein products that encoded by mitochondrial DNA are not expressed, 
including 13 essential subunits of electron transport chain enzymes. [32] More 
importantly, electron transport is coupled with ATP synthesis. As shown in the 
chemiosmotic model in Figure 4. 
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Fig. 4 
Electron flow is accompanied by proton transfer across the membrane, 
producing both a chemical gradient and an electrical gradient. The inner 
mitochondrial membrane is impermeable to protons; protons can reenter the 
matrix only through proton-specific channels. The proton-motive force that 
drives proton back into the matrix provides the energy for ATP synthesis. [33] 
 
As a result, there is no ATP production in mitochondria (oxidative phosphorylation) 
when electron transport is dysfunctional. However, even without oxidative 
phosphorylation, cells can still produce small amounts of ATP through glycolysis, 
which is performed in the cytosol. Consequently, on fermentable media cells can still 
grow when treated with erythromycin. In another word, both wild types and mutants 
can grow on this medium (only the matter of speed).  
To avoid this happening, N3 plates are being used. N3 plates differ from YPD plates in 
the supply of carbon source, having glycerol instead of glucose. Different from glucose, 
glycerol can only be catabolized in mitochondria, since the enzymes of glycerol 
oxidation are located in the mitochondrial matrix. [34]  
Therefore, mitochondria become the only place where ATP can be synthesized. And 
once erythromycin is added to these N3 plates, only cells harbouring the specific rib2 
and rib3 mutations will grow. 
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4.4 Erythromycin Resistance 
The specific sites at which a mutation can lead to resistance to erythromycin are 
located within two ribosomal loci rib2 and rib3. (Illustrated in Fig.5) Both of rib2 and 
rib3 genes encode the 21S rRNA. In the rib2 locus, when a cytosine is replaced by a 
guanine at the 3993 position on the non-coding strand, which leads to a C·G → G·C 
transversion, the mutant obtains resistance to erythromycin. Similarly, when an 
adenine is substituted by a guanine at the 1951 position, resulting in an A·U → U·A 
transversion, the mutant then displays resistance to erythromycin. [35]  
 
Fig.5 
Model depicting the folded structure of the mitochondrial 21S rRNA comprising 
a peptidyl transferase loops in the ribosome unit. Within 21S rRNA the mutation 
sites conferring erythromycin resistance are located in the rib2 and rib3 loci. [35]  
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5 Experimental process  
 
5.1 Sir T1 
PCR  
First of all, we made PCR reaction solution; by doing this, cDNA and dNTP which 
were kept cold are mixed with primer set, Advantage Taq Polymerase, Advantage 
buffer and sterile water in a PCR tube which makes up 50µl (see Appendix). The 
forward primer contains the first eighteen bases of SirT1 gene and the recognition 
sequence of BamHI, and the reverse primer consists of the last twenty bases of SirT1 
gene and the recognition sequence of XhaI. 
The two restriction enzymes, XbaI and BamHI, have recognition site 5’T^CTAG_A 3’ 
and 5’G^GATC_C3’ respectively;  
First eighteen bases sequence and last twenty bases sequence of SirT1 are 
TGGAAGATGGCGGACGAG and CTATGATTTGTTTGATGGATAGTTC, 
repectively.  
After mixing, 25µl are transferred to a new PCR tube and two PCR programs were run 
with annealing temperature 64°C and 60°C respectively, for 30 cycles.  
After PCR, we checked the PCR reaction by loading 5µl PCR product with loading 
buffer on an agarose gel for electrophoresis. After 2 hours at 100 voltage, we did not 
see the band around 2243bp (the SirT1 longevity gene) which we expected on the gel.  
Considering that the chosen temperatures did not work, we changed them to 58°C and 
54°C. As to demonstrate a successful PCR reaction at 58°C and 54°C, we also made 
one positive control tube (GAPDH), it has an optimal annealing temperature at 57.5°C. 
At both temperatures we got the expected 983bp PCR product with GAPDH-For and 
GAPDH-Rev primers (primer sequences see Appendix 2) on human cDNA (see 
Appendix 12 figure1 ). 
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Using the above methods, this time in the SirT1 reaction, we got a very thin band 
around 2243bp in using the annealing temperature 54 °C. This amount is much less 
than we expected.  
 
Purification  
Because of the insufficient amount of our SirT1 PCR product, we have to amplify it to 
a proper amount before we will be able to clone it into pYES2. First, by using High 
Pure PCR product purification spin column, we should have our pure PCR fragment 
without primers, dNTP and so forth. 
To begin with, we add binding buffer to get rid of polymerase, double stranded DNA 
and/or single stranded DNA that smaller than 100 bp, such as primers, and low 
molecular weight compounds like dNTPs. That is because under high salinity with pH 
≤ 7.5, large double stranded DNA which is larger than 100 bp would bind to the 
column immobilized material while others can not. Afterwards, using wash buffer to 
ensure the complete removal of all the stuff stated above and get an optimal pure PCR 
product. At last, by using elution buffer that with low salinity and pH equals to 8.5, our 
desired pure DNA fragment eluted. (See Appendix 4 for details) 
 
To make sure our PCR fragment still exists, we ran another agarose gel electrophoresis. 
This time, unfortunately, we had no visible band around 2243bp where it supposed to 
be. But we still believe that small quantities of the PCR fragment is there, considering 
there was so little of it before purification. 
 
Therefore, we decided to clone the invisible PCR fragment into a TOPO vector by TA 
cloning. If successful the cloned fragment can be transformed into E. coli and thus be 
amplified and subsequently purified and used for pYES2 cloning. TOPO vector has 3' 
deoxythymidine (T) overhangs which bond to 3' A overhangs of the PCR fragment at 
the presence of topoisomerase I. Due to its useful feature, such as ampicillin and 
kanamycin resistance markers, as well as a lacZ reporter gene, it is an efficient method 
for cloning PCR fragment. 
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Transformation 
To begin with, we mixed TOPO vector with the PCR fragment and then incubated at 
room temperature for 15minutes. Afterwards, we transferred our plasmids to 
competent XL10Gold cells and incubated on ice for 15min. And also, a positive 
control was performed. (See Appendix 5 for details) 
Finally, the cells were plated on LB plates which contained ampicillin. On the second 
day, the positive control plate had enormous amounts of colonies; but for our DNA 
sample plate there were only few colonies. Then we picked up some colonies from the 
plate and incubated them in 5ml YPD medium separately for overnight. Hopefully 
there will be some colonies with our desired SirT1-TA plasmids. And now it is 
prepared for purification. 
 
Gene Elute 
Using the Gene Elute Plasmid Miniprep kit, to get pure SirT1 -TA plasmid there are 
five steps: 
First, we harvested and lysed the bacteria. Second, the cleared lysate was prepared. 
Third, we bound the plasmid DNA to the column. Fourth, we washed to remove 
contaminants. And finally, the purified plasmid DNA was eluted. (See Appendix 6 for 
details) 
Gen Elute Plasmid Miniprep Kit is a fast and convenient method for preparing pure 
plasmid from bacteria cell. By adding lysis solution to over night culture, the cell walls 
were broken. Then we bound plasmid onto mini-spin column in high salt condition, 
mini-spin column contain silica on its bottom. At the end, contaminants are removed 
by adding wash solution to the column; then the elution solution is used to wash 
plasmid from silica layer. Now pure plasmid is ready for restriction digestion. 
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Restriction Digestion 
We used the purified plasmid DNA mixed with BamHI, XbaI and EcoRI. We expect 
three fragments after digestion with 4kb (topo-TA vector), 2.1kb (PCR fragment) and 
170bp (PCR fragment) respectively. (See Appendix 7 for details) For Topo-TA vector 
and human SirT1- PCR map, see Appendix 8 for detail. The Figure2 gel 
electrophoresis in Appendix 12 did not show the three thick bands as we expected. We 
concluded that human SirT1 gene could not be cloned under our experimental 
conditions, and then we had to change to zero in on the yeast Sir2 gene instead. 
 
5.2 Sir 2 
We got the PCR product of Sir2 gene from group β. In principle, it is the same 
procedure as we dealt with trying to clone the SirT1 gene except that the Sir2 gene is 
derived directly from yeast genomic DNA and the PCR reaction ran with different 
primers and annealing temperature. 
 
Restriction enzyme digestion 
We digest both our Sir2 PCR product and pYES2 plasmid by EcoRI and XhoI at 37°C 
for approximately 2 hours and then checked by running agarose gel 
electrophoresis.(see Appendix 9 for details) We estimate there will be bands around 5.9 
kb for pYES2 and 2.0 kb for the Sir2 PCR fragment. Here we got a good result in 
agreement with our expectations (see Appendix figure 12 figure 3). 
 
Purifying DNA fragments from agarose gels 
We use a different kit for purification which is called High Pure PCR product 
purification kit. It extracts and purifies DNA fragments from standard or low-melt 
agarose gels in TAE or TBE buffer. This process is similar to the High Pure PCR 
product purification spin column used above; it also uses binding buffer, wash buffer 
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and elution buffer to extract desired DNA fragments. The difference is that here we 
should melt the agarose gel first. (See Appendix 10 for details) 
 
Ligation 
After digesting and purifying the Sir2 fragment and pYES2 vector, we need to transfer 
the Sir2 fragment into the pYES2 vector. First, we mix the Sir2 fragment and pYES2 
vector, buffer, H2O and ligase in an E-tube. In order to compare with the pYES2 vector 
with Sir2 fragment, we made a negative control in which water is added instead of the 
Sir2 fragment. (See Appendix 11 for details) 
The principle is that we used the same restriction enzymes to digest both the Sir2 
fragment and the pYES2 vector, so they would have complementary staggered ends 
which lead them to bind spontaneously; ligase is used to seal the gaps in the sugar 
phosphate backbone. 
 
Transformation of competent XL10Gold cells 
The ligation mixtures need to be transferred into competent XL10 Gold cells. First, we 
mixed the ligation mixture and Gold cells and incubated them in a water bath at 42oC. 
Secondly, we spread the suspended bacteria on the pre-dried plates containing 
ampicillin. The plates containing ampicillin is used to select the bacteria colonies that 
have taken up the pYES2 plasmid (that includes an ampicillin resistance marker, see 
figure 6 below or Appendix 8). 
In order to check the transformation procedure, we made a negative and a positive 
control. The negative control is the pYES2 plasmid digested with restriction enzymes 
but without ligation treatment. The positive control is the original pYES2 plasmid 
without modifications. 
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Extraction of pure plasmid 
After incubating the transformed cells, we need to extract the pure plasmids from these 
bacterial cells. Firstly, we spun down the overnight culture, and discarded the 
supernatant. Then we added lysis solution to make the plasmids come out of the 
bacterial cell walls. Secondly, we spun again after adding the neutralization solution 
which is used to separate the plasmid from the other bacterial debris. Finally, we 
purified the plasmid by binding the plasmid DNA to columns and washing to remove 
contaminants. The plasmid preparation is a mixture of different ligation products. 
Among these we need to identify the pYES2 vector with the Sir2 gene using restriction 
analysis. 
 
Check by restriction enzyme digestion 
In order to check if any of the tranformants contain the Sir2 fragment cloned into the 
pYES2 vector, we made two groups of restriction enzyme digestions, for one group we 
used the restriction enzymes EcoRI and XhoI, as shown in the figure below, the vector 
will be cut into two fragments: 5.8 kb and 1.7 kb. The other restriction enzyme is 
BamHI, in this group we will get 3 different pieces of DNA fragments: 6.7 kb, 550 bp, 
and 300 bp. 
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Fig. 6  
pYES2+Sir2 plasmid 
 
The restriction digestion is to check if there is an insert of the expected size and if the 
restriction pattern of the insert can confirm that it is the Sir2 gene that is cloned into the 
pYES2 vector. 
The two groups of DNA fragments were checked by running gel electrophoresis. The 
basic principle is that the DNA is negatively charged, if voltage is applied, the DNA 
fragments will run down, and the smaller fragments run faster than the bigger ones. 
Our result is obvious; we can find every fragment we expected except 550bp and 300 
bp, which are not very clear (see Appendix 12 figure 4). 
 
 
Yeast transformation   
In order to get yeast single colonies, wild-type yeast strain (YO) cells are collected on 
sterile toothpicks and streaked on to YPD plates; To obtain single colonies a second 
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streak was made perpendicular by another sterile toothpick, and the third was made 
across to second by same manner. 
After incubating for 2 days, a single colony was picked and inoculated in liquid YPD. 
And then, it was incubated in shaking water bath together with non-inoculated YPD 
medium (negative control, it was used as a reference to monitor the sterilization of 
YPD medium). 
 
The overnight culture was transferred into YPD medium and incubated a in shaking 
water bath for the purpose of making more colonies. 
 
DNA coming from heering/ salmon testes was denatured and centrifugation of the 
cultures  was carried out. Supernatant (YPD medium) was discarded, and cell pellets 
weree collected and re-suspended in sterile water. Centrifugation was used again to 
concentrate the cells, which were re-suspended in TE/LiAC solution (to make them 
competent). 
Three eppendorph tubes were prepared with the same volume of Sir2-pYES2 construct, 
empty pYES vector, and sterile water respectively. At the same time, also add 
PEG/LiAc and denatured heering/salmon tests carrier DNA to each tube. PEG/LiAc is 
used to break cell wall. When foreign DNAs introduced into the host cell, the host will 
attack and degrade them, in order to prevent our desired plasmids from the attack, we 
introduce the denatured heering/salmon testes carrier DNA into the host cells along 
with the plasmids transformation; as a result, the host will attack our plasmids at a rare 
frequency. 
 
DMSO was added to each tube, DMSO is also used to break the cell wall, making sure 
that the plasmid have ben introduced into the host yeast cell. Cells were heat-shocked 
in a heating block again, centrifuged in an Ole Dick centrifuge and supernatant was 
removed. Pellets were re-suspended in TE buffer. 
  
Transformed cell cultures were plated on SD-Ura plates, to select the cells which were 
carrying the pYES2 plasmid. As we expected, there are no colonies on SD-Ura plate in 
the negative control with sterile water, but we got colonies in the pYES2 
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transformation and in the pYES2-Sir2 transformation. 
As to get single colonies, one colony taking from SD-Ura plate was streaked to single 
colonies on a new SD-Ura plate. Three of each was incubated in liquid SD-URA at 30 
°C in a shaking water bath. Next day 600 μl overnight culture was mixed with 300 μl 
sterile glycerol to make “empty pYES vector strains” and “Sir2-pYES2 construct 
strains”. These two types of strains were kept at -80 °C and were subsequently used in 
the erythromycin assay. 
 
 
Pilot Assay 
In the pilot assay, three strains are used to evaluate the feasibility of the experimental 
design. 
The three strains are: YO (wild type), Sir2- (Sir2 deletion strain) and MSH1- (MSH1 
deletion strain). (MSH1 is a mitochondrial DNA repair protein.) 
All three strains are inoculated on the prepared N3 plates which are able to select cells 
with full respiratory function (to ensure the growing cells with full mitochondrial 
function). However, no cells were grown on MSH1- plate after inoculating. Thus we 
decided to ignore the MSH1- strain. 
For the rest two strains, three colonies were picked from each plate and put separately 
to the prepared 50mlYPD medium, and all 6 flasks were put into the 300C vigorous 
shaking water bath over night. 
On the second day the supernatant of the 6 tubes are taken out after centrifuge them for 
a few minutes. After discarding the supernatant, we get only cells in the tube. 
400 and 300 sterile water are added to all three tubes of YO and Sir2- respectively, and 
then all the tubes are diluted with 10, 102,103,104,105,106 and 107 times. After that the 
tubes with dilution factor of 10,102,103 are measured with OD600. The dilution with an 
OD600 closest 0.5-0.6 is chosen to calculate the cell density according to Protokol 1: 
Cellteaethed maalt med OD660 (see Appendix 16). From the estimated number of 
cells/ml, the numbers of cells in the plating volume (200ul) of this as well as the other 
dilutions are calculated. From these calculations, the dilutions that are expected to 
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yield 30-300 colonies per YPD plate are plated. The result we get shows dilution with 
106 and 107 are suitable for plate on YPD plates. 
On the other hand, the undiluted original cultures are plated on the N3E (erythromycin) 
plates, and the total volume of the culture plated on N3E plates is measured by 
adjusting the pipette. 
With the numbers of colonies on YPD and N3E plates, we are able to calculate the ER 
causing mtDNA mutation frequency. The number of erythromycin resistant colonies is 
divided by the calculated total number of viable cells in the plated volume. 
The pilot assay is trial assay for the real assay. Thus the processes of the two assays are 
almost the same. 
 
 
Erythromycin Assay (Real Assay) 
As mentioned above, the process of Real Assay is similar to the pilot assay. Except the 
several differences: 
 
1st: Beside the 2 strains YO and Sir2- we added a new strain, Ogg1-, which is 
considered as the positive control. 
  
2nd: We add 2 transformants into the real assay. They are pYES2 (empty plasmid) and 
pYES2+Sir2 (over expression) 
 
3rd: The two transformants are all grown and incubated on SD- Ura plates. Since the 
growth rate is slow on SD- Ura plates, we keep the vigorous shaking water bath for 2 
days. 
 
The SD- Ura plate is used to select the transformants. Unlike the dependency of uracil 
of normal yeast, the pYES2 containing cell (transformants) is able to survive from the 
Ura- situation due to the presence of the Ura3 promoter in pYES2. 
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In order to make the Sir2 over expressed, we added 5.5ml 1% galactose to the 
incubation tubes. The galactose promoter in the pYES2 will make Sir2 over expressed 
in the cell. 
 
5.3 Flow-chart  
(Only the main process included, detailed process seen in text) 
 
PCR 
(Amplify target Sir2 gene) 
↓ 
Restriction enzyme digestion 
(To form palindrome cut patterns on both ends of Sir2 gene and pYES2 vector so that 
the Sir2 gene can be incorporated into pYES2 vector by complementary base-pair) 
↓ 
Ligation 
(Join Sir2 gene and pYES2 vector by ligase to form pYES2-Sir2 plasmid) 
↓ 
Transformation of competent XL10 Gold cells 
(Amplify pYES2-Sir2 plasmid) 
↓ 
Extract pure plasmid and check by restriction enzyme digestion 
(Make sure we get the right pYES2-Sir2 plasmid) 
↓ 
Transformation of yeast Saccharomyces cerevisiae cells 
(Derive yeast cells with Sir2 gene over expressed) 
↓
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Incubate transformants in SD-Uracil plates 
(Confirm the plasmid have been transformed  Inoculate YO, Sir2 deletion and  
into yeast cells)                           ogg1 deletion strains 
                        ↓                 ↓ 
Incubate all five kinds of yeast cells 
↓ 
Dilute the culture till proper OD600 (0.4-0.5) is observed 
(Derive optimal accurate cell density for operating assay) 
↓ 
Assay, 3 YPD plates and 3 N3E plates are made for each kind of yeast cell 
(Using diluted culture for plating on YPD to obtain cell numbers under normal growth 
during the time interval while applying original culture for plating on N3E to derive 
mutant cell numbers) 
↓ 
Calculate the mitochondrial DNA mutation frequency 
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6 Results and Discussion  
 
6.1 Experimental Results  
Calculation of the frequency of ER cells 
 
200µl of the 106 and 107 dilutions were plated on a YPD plate respectively.  After 
incubation for 2 days, there are X colonies on the plate representing the 106 dilution.  
 
Total number of colonies in 200µl undiluted culture is then = X * dilution factor 
Three times 200µl of each undiluted culture had been plated on separate N3E plates, 
after 10days, there were a, b, c colonies on these three plates, respectively. From this 
the average number of ER colones in 200µl undiluted culture is Y= (a+b+c)/3  
 
Erythromycin resistant colony frequency is then  = Y/ (X * dilution factor)  
 
In this experiment, first we made one pilot assay and the number of mtDNA mutated 
cells is presented as the number of erythromycin resistant cells per 105 cells. In this 
assay, we picked respiratory competent colonies from N3 plates and inoculated them in 
YPD medium. Table 1 show the values which we have obtained from this assay. 
 
 
 
 
 
 34 
 
Table 1: Wild type (YO) and deletion Sir2 strains, each strain has three replicate 
cultures, each culture makes three replicate N3E plates. Y is average value of 
erythromycin resistant colonies on three replicate plates and X is the number of 
colonies on the dilution factor 106 YPD plate 
 
dilution factor 106 X Y 
The number of 
ER per105 
YO1 345 45 1.3 
YO2 269 27 1.0 
YO3 379 31 0.8 
SIR2-1 107 22 2.06 
SIR2-2 160 16 1 
SIR2-3 235 18 0.72 
 
In table 2, it can be seen that the number of erythromycin resistant colonies/105 cells on 
YO plates and deletion Sir2 plates look very alike. Only the first “Deletion of Sir2 
plate” has higher value than the wild type plates .So, this pilot experiment cannot 
determine that the deletion of Sir2 causes a higher mutation frequency in 
mitochondrial DNA. It only tells us that this assay protocol seems feasible. 
 
In the later assay, the real experiment assay, wildtype and deletion strain colonies were 
picked from YPD plates and inoculated in YPD medium. The pYES2 and pYES2-Sir2 
transformants were picked from SD-URA plates and were grown in liquid SD-URA 
supplemented with 1 % galactose to induce expression from the GAL-promoter. In 
table 2 the values are shown and the frequency of mtDNA mutations is presented as the 
number of erythromycin resistant cells per 106 cells. 
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Table 2: Five genotypes were used: YO, Sir2- , Ogg1-, Sir2-pYES2 and empty 
pYES2. For each genotype, three replicate assays were made; each assay makes 
three replicate plates. The value of each culture is the average value of three 
replicate plates, as in the pilot assay. 
a: the plating volume is 100μl 
b: the calculation for mutation frequency= 2*Y/ (X * dilution factor) 
The bold numbers are included in our calculation while the others are excluded. 
 
Dilution factor 107 X Y 
The number of ER 
per106 
YO 1 118 24 2.0 
YO2 328 867 26.4 
YO3 105 0 0 
Sir2- 1 94 34 3.6 
Sir2- 2 74 0 0 
Sir2- 3 157 10a 1.3b 
Ogg-1 193 0 0 
Ogg- 2 96 0 0 
Ogg-3 154 0a 0b 
Sir2-pYES2   1 70 0 0 
Sir2-pYES2   2 75 65 8.7 
Sir2-pYES2   3 96 3a 0.6b 
pYES2     1 84 40 4.8 
pYES2      2 67 5 0.7 
pYES2      3 61 8 1.3 
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In the culture YO1, erythromycin resistant colonies grew intensively, and in the culture 
YO2, colonies looked tiny. So without identification we could not show that they were 
yeast cells or contamination. They were therefore examined microscopically and 
determined to be yeast cells, by comparing their diameter 3-4μm with human cell’s 
diameter 15μm. No erythromycin resistant colonies grew on the deletion Ogg1 plates 
in this assay. As this was our positive control, this was unexpected. In other 
experiments which deal with the Ogg1 DNA repair gene and its effects on 
mitochondria, it is demonstrated that an inactivation of Ogg1 leads to at least a 2-fold 
increase in production of mitochondrial mutants compared with wild types. [38]  
In table 2 it can be seen that the number of erythromycin resistant colonies within each 
genotype vary a lot.. It could be caused by various factors. Jackpots could be one of the 
error factors, which will give a large value of the erythromycin resistant colonies, 
because cells have a longer period to divide. YO2 and Sir2-pYES2 2 samples could be 
caused by jackpots. The YO2 plate which gave an extremely high number of mutants 
could also be considered to be due to contamination. 
Excluding error values, taking an average of the remaining values, results depicted in 
figure 7: 
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Fig. 7 The frequency of erythromycin resistant colonies of yeast cells with four 
different genotypes. Compared with wild type (YO), the Sir2- strain gave an 
approximately 1.25 fold increase in production of mutants while the 
over-expressed Sir2 cut down the mutation frequency by 2/3. 
 
In figure 7, it can be seen that the number of erythromycin resistant colonies in the 
deletion Sir2 strain exceeds the number of erythromycin resistant colonies in wild type, 
and is about 1.25 times higher. What is more, the number of erythromycin resistant 
colonies of over-expressed Sir2 (Sir2-pYES2) is obviously lower than the number of 
erythromycin resistant colonies in wild type, it is about 1/3 of the number of wild type 
mutants. The number of erythromycin resistant colonies with empty yeast plasmids 
lies at a higher lever compared with the wild type, this implies that the reduction in 
mutant numbers is caused by the over-expressed Sir2 and not affected by pYES2 
vectors. 
The deletion of Sir2 gene has been reported to shorten the yeast life span by 
approximately 50% and in contrast, an over-expressed Sir2 gene gives a 30%-40% 
increase in life span. [39]  
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In our experiment, the tendency of Sir2 gene in regulating the production of mutants is 
in accordance with others’ research; that is the deletion of Sir2 induces a higher 
mutation frequency and conversely over-expressed Sir2 reduces the mutation 
frequency.  
 
Above all, one of the longevity effects of Sir2 could manifest itself as a reduced 
mtDNA mutation frequency. 
In the following figure, we demonstrate a brief relationship between Sir2 and CR. 
 
 
The Sir2 encoded protein (Sir2 deacetylase) regulates longevity by reducing the rate of 
ERCs formation by two mechanisms. The Sir2 acts indirectly to inhibit ERC formation 
by preventing the simultaneous expression of a and α mating-type genes ( process [i] in 
the figure above). Sir2 deacetylase acts by a second mechanism in the rDNA to inhibit 
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Fob1p-mediated formation of ERCs, presumably at blocked replication forks.[4] 
 
On the other hand, CR is thought as Sir2 deacetylase inducer, the increases of CR in 
the cell will increase the NAD+ and consequently activate Sir2 deacetylase, thus 
slowing aging. However, recent researches also find that CR has a Sir2-independ life 
span extension pathway. The following figure is describing the method well. 
 
 
 
Three conditions are described in the figure above: with the presence of both Fob1 and 
Sir2, the Sir2 as well as CR will slowing the aging parallel. In the cells lacking Sir2 but 
containing Fob1, the life span is shortened rapidly, since both pathways are not 
working. In cells lacking Fob1, ERCs are greatly reduced and CR pathway 
predominates. The presence or absence of Sir2 does not impact the longevity benefits 
of CR under these conditions. [3] 
 
In our report we investigate the question mark in the figure above. If the Sir2 gene can 
reduce the mutation frequency in mtDNA, it can then increase the life span in the yeast 
by a so far undescribed pathway  
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6.2 Prospects of the experiment 
 
The experiment performed by us is a results-only experiment; it will not be able to 
illustrate the specific pathways of how the Sir2 gene regulates the metabolism of 
mitochondria. Also, we wanted to do the same research with SirT1 as our target gene, 
but due to the lack of experience and equipment we didn’t succeed. Thus further 
experiments are needed in order to finish the rest of the research. In this section we will 
talk about some of these issues and possible improvements of this experiment. 
 
At the beginning of the experimental design, we were about to use SirT1 as our target 
gene. Since SirT1 gene is the ortholog of Sir2, from the behavior of SirT1 gene to the 
yeast, we could expect that it may have the same potential effect as Sir2 on mediating a 
reduced mtDNA mutation frequency in mammals, thus slowing the aging. However, 
the experiment failed because of failure of PCR-amplifying the SirT1 gene, the reasons 
of failure are still not known, there may be a possibility that SirT1 gene can’t be 
PCR-amplifyed by the method we used (from a human cDNA ibrary). We think the 
main focus should be addressed to the method of PCR-amplifying the SirT1 gene, 
since the SirT1 fragment band on gel electrophoresis after amplification remains faint. 
From the results of our experiment it seems that the Sir2 gene is able to reduce the 
mutation frequency in mtDNA compared to a Sir2 deficient strain, as we expected, and 
adding an extra copy of Sir2 seem to have an even better effect. What is not clear is the 
specific pathway of how the Sir2 gene mediates the reduction in the mutation 
frequency. The relationship between CR (calorie restriction) and the Sir2 gene has 
been investigated recently, and also the independent ability of Sir2 to reduce the toxic 
rDNA circles in yeast mother cells. As mentioned, some research indicates that Sir2 
and CR act paralleled [41] 
Due to this matter of fact, it will also be interesting to see if changes in mtDNA 
mutation frequency are mediated by Sir2 and CR in parallel or if there are overlapping 
pathways/mechanisms. However, more design on the detailed procedure is required. 
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7 Conclusion 
 
In this experiment, the effect of Sir2 on mitochondrial DNA mutation frequency is 
studied. According to the result obtained, we conclude that the expression of Sir2 is 
responsible for reducing the mutation frequency of mitochondrial DNA (lower the 
number of colonies on erythromycin plates) in yeast. Comparing with wild type, 
over-expressed Sir2 and Sir2 deletion strains gave an increase of 25% and a decrease 
of 66.7% of mtDNA mutation frequency, respectively. However, during the 
experiments, we encountered some errors, for example: jackpots, which will give 
larger value of the number erythromycin resistant colonies, because cells have a longer 
period to divide. If more time is allowed, assaying more replicate plates will give us a 
better result. According to our experiment, we can not tell how Sir2 regulates the 
mitochondrial DNA mutation frequency in yeast cell. Thus further experiments are 
needed for detailed research. However, there is a possibility that expressed Sir2 is able 
to reduce the mutation frequency of mitochondrial DNA. 
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8 Appendix 
Appendix 1 
PCR with Advantage Taq (Clontech) 
Notes: 
The cDNA template and dNTPs are thawed just before use and kept on ice. 
The PCR reactions are prepared on ice. Add Advantage Taq Polymerase last. 
The PCR machine is prewarmed to 94oC and then paused. The tubes are put in and the 
program continued (hot-start). 
A touchdown PCR protocol is used in which the first 5 cycles have a higher annealing 
temperature to reduce non-specific annealing. 
Mix together in a PCR tube on ice: 
 
5 µl cDNA template 
4 µl primer set (5 pmol/µl each) (BamH1 and Xbal1) 
34 µl sterile water 
5 µl 10 x Advantage buffer (Clontech) 
1 µl 10 mM dNTPs 
1 µl Advantage Taq Polymerase (Clontech) 
50 µl 
 
After mixing, transfer 25 µl to a new PCR tube and run two PCR programs: 
 
PCR program 1: 
1 cycle  94oC 2 min (prewarmed block) 
5 cycles 94oC 30 sec, 68oC 3 min 
30 cycles 94oC 30 sec, 64oC 30 sec, 68oC 3 min 
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1 cycle  68oC 5 min 
1 cycle  10oC 
 
PCR program 2: 
1 cycle  94oC 2 min (prewarmed block) 
5 cycles 94oC 30 sec, 68oC 3 min 
30 cycles 94oC 30 sec, 60oC 30 sec, 68oC 3 min 
1 cycle  68oC 5 min 
1 cycle  10oC 
Check 5 µl PCR reactions on an agarose gel with 1µl loading buffer. 
First, the annealing temperature is 64oC and 60oC respectively in two programs, then 
change them into 58 oC and 54 oC at second time. 
 
Appendix 2 
Primer Sequences 
Sir2-For 5’-CGGAATTCAAGATGACCATCCCACATATGAAATAC-3’ 
(EcoRI) 
Sir2-Rev 5’-GACCTCGAGTTAGAGGGTTTTGGGATGTTC-3’ 
(XhoI) 
SirT1-For 5’- GACGGATCCTGGAAGATGGCGGACGAG-3’ 
(BamHI) 
SirT1-Rev 5’-GACTCTAGACTATGATTTGTTTGATGGATAGTTC-3’ 
(XbaI) 
GAPDH-For 5’-TGAAGGTCGGAGTCAACGGATTTGGT-3’ 
GAPDH-Rev 5’-CATGTGGGCCATGAGGTCCACCAC-3’  
(Expected PCR product with GAPDH-For and GAPDH-Rev on human cDNA is 983 
bp) 
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Appendix 3 
Preparation of 1 % agarose gel 
In a conical flask add: 
1 g agarose 
100 mL 1 x TBE buffer 
Bring to boil in microwave oven. Cool down to approx. 70 %. Add 10 µL 
ethidiumbromide (Note: toxic and carcinogenic – wear gloves!!!). Pour into gel casting 
tray and place the appropriate combs in the slots. Let the gel set. 
 
Running the gel 
 
Remove tape and combs from the gel in the casting tray, and place it in the buffer (1 x 
TBE) in the running chamber. Remember to place it correctly according to the 
electrodes! Make sure the gel is covered by buffer. 
 
Mix DNA samples with loading dye (6x) (in a tube or on a piece of plastic), e.g. 5 µL 
sample + 1 µL loading dye. Add samples to the well by inserting the tip of the pipette 
into the well but without touching the bottom (or sides). Use both hands to keep the 
pipette steady. Remember to load a DNA ladder to help determine the size of DNA 
fragments. 
 
Place lid on tray and make sure the electrodes are connected to the power supply 
correctly. Turn on power supply and run gel at 100 V until the blue dye is 1 cm from 
the bottom (depending on the size of the fragments of your interest). 
Turn off power, remove lid and remove gel (wear gloves). Take a picture of the gel 
under UV-light to visualise the DNA fragments. Compare the size of your fragments 
with the DNA ladder. 
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Appendix 4  
High Pure PCR product purification spin column 
? The High Pure columns (from Roche Applied Science) have a maximum capacity 
of up to 25 µg DNA. 
? The binding buffer (green cap) contains guanidine hydrochloride which is an 
irritant. Wear gloves and follow usual safety precautions when handling. 
? Add 5 volumes of binding buffer (green cap) to the PCR product and mix well 
? Place a High Pure spin column in a collection tube and pipette the sample into the 
column 
? Centrifuge 30 sec at 13 K 
? Empty the collection tube and put the column back into the same tube 
? Add 0.5 ml wash buffer (blue cap) to the column, centrifuge 30 sec at 13 K 
? Empty the collection tube and put the column back into the same tube. Add 0.2 ml 
wash buffer (blue cap) to the column, centrifuge 30 sec at 13 K 
? Place the column in a new 1.5 ml E-tube where the lid has been cut off and discard 
2-log DNA ladder (New England Biolabs) 
 
Description:  
A number of proprietary plasmids are digested to 
completion with appropriate restriction enzymes 
to yield 19 bands suitable for use as molecular 
weight standards for agarose gel electrophoresis. 
This digested DNA includes fragments ranging 
from 100 bp to 10 kb. The 0.5, 1.0 and 3.0 kb 
bands have increased intensity to serve as 
reference points. The approximate mass of DNA 
in each of the bands is provided (assuming a 1.0 
μg load) for approximating the mass of DNA in 
comparably intense samples of similar size. 
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the collection tube 
? To elute the DNA add 30 µl elution buffer (vial 3) or TE buffer or sterile H2O to 
the center of surface of the column. Wait 3 min. Centrifuge 30 sec at 13 K. Discard 
the column 
? If the DNA is eluted in H2O it should be stored -20°C to avoid acid hydrolysis. 
 
Binding buffer:  3M guanidine-thiocyanate, 10 mM Tris-HCl pH 6.6, 5% EtOH 
Wash buffer:  20 mM NaCl, 2 mM Tris-HCl pH 7.5, 80% EtOH 
Elution buffer:  (TE) 10 mM Tris-HCl, 1 mM EDTA, pH 8.5 
 
 
 
Appendix 5 
TOPO-TA cloning reaction 
Mix together: 
3.2 µl PCR fragment (DNA) 
0.8 µl salt solution (kit) 
0.8 µl TOPO vector (kit) 
 
Incubate 15-30 min at room temperature. Afterwards place on ice. 
Salt solution: 1.2M NaCl2 and 0.06M Mg Cl2 
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Transformation of competent XL10Gold cells (E. coli bacteria) 
 
? Prepare tubes with DNA for the transformation and place these on ice. Use 5 µl 
ligation mixture or 10µl positive control plasmid in pr. tube. 
? Thaw a tube of competent XL10Gold cells just before use. Put on ice. 
? Add 100 µl competent cells to each tube, mix gently, and incubate on ice for 15 
min or longer. 
? Heat shocks the transformation mixture by incubation in a water bath at 42°C for 
exactly 45 sec (or in a heat block for 2 min). 
? Immediately transfer the tubes to ice. 
? Add 500 µl LB medium to each tube and incubate at 37°C for about 1 hour, with 
shaking. 
? Spin 5000 rpm for 2 min, discard most of supernatent. Resuspend bacteria in the 
remaining liquid (ca. 150 ul) and plate everything. 
? Spread the bacteria on pre-dried plates containing antibiotic. 
? Incubate plates at 37 oC overnight. 
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Appendix 6 
Genelute Plasmid Miniprep Kit 
All spins at max. speed. 
1. Harvest & lyse bacteria 
? Pellet cells from 2 ml overnight culture 1 min. 
Discard supernatant. 
? Resuspend cells in 100 µl Resuspension 
Solution. Pipette up and down or vortex. 
? Add 200 µl of Lysis Solution. Invert gently to 
mix. Do not vortex. Do not allow to stand for 
more than 5 min. 
2. Prepare cleared lysate 
? Add 350 µl of Neutralization Solution. Invert 
4-6 times to mix. 
? Spin 10 min to pellet debris. 
3. Bind plasmid DNA to column 
? Prepare mini-spin column in a collection tube: 
Add 500 µl Column Preparation Solution to 
column. Spin 30 sec – 1 min. Discard 
flowthrough. 
? Transfer cleared lysate into column. 
? Spin 30 sec – 1 min. Discard flowthrough. 
4. Wash to remove contaminants 
? Add 750 µl Wash Solution to column. Spin 30 
sec – 1 min. Discard flowthrough. 
? Spin 1 – 2 min to dry column. 
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5. Elute purified plasmid DNA 
? Transfer column to new collection tube. 
? Add 50 µl elution solution. Wait 1 min. Spin 1 min. DNA is in collection tube. 
 
 
Appendix 7 
SirT1 PCR product Restriction enzyme digestions 
For each digestion: 
2-5 µl miniprep DNA 
0.5 µl enzyme (NB: Restriktion enzyme: keep on ice and add last (supervisor) (BamH1, 
Xbal1 and EcoR1) 
2 µl 10 x restiction buffer 
Up to 20 µl with H2O 
 
Prepare a (n + 1) premix without DNA. Add 15 µl premix and 5 µl DNA in each tube, 
we have 6 tubes in here. 
 
 1 miniprep DNA n + 1 miniprep 
DNA 
DNA 5 µl µl 
buffer 2 µl 14 µl 
H2O 12.5 µl 87.5 µl 
Enzyme 0.5 µl 3.5 µl 
Σ (volumen i alt) 20 µl µl 
 
Mix the digestions gently and incubate 1 - 2 hours at 37oC. 
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Appendix 8 
Topo-TA vector, human SirT1-PCR map, Sir2-PCR map, pYES2 
vector and pYES2-Sir2 plasmid 
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Appendix 9 
Sir2 PCR product and pYES2 plasmid Restriction enzyme digestion 
Sir2 PCR product: digest 5 µl in 30 µl Σ (total volume) 
pYES2 plasmid: digest 5 µl in 30 µl Σ (total volume) 
for each digest: 
 
1 µl of each EcoRI/XhoI (Note: the enzyme is added last!) 
3µl EcoRI buffer 
up to 30 µl with H2O 
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 Sir2 PCR product pYES2 
plasmid 
DNA 5µl 5µl 
buffer 3µl 3µl 
H2O 20µl 20µl 
Enzyme 1 1µl 1µl 
Enzyme 2 1µl 1µl 
Σ (total volume) 30 µl 30 µl 
 
The digest are mixed well and incubated for approx. 2 hours at 37°C. 
 
 
 
Appendix 10 
Purifying DNA fragments from agarose gels with High Pure PCR 
product purification kit 
This protocol is designed to extract and purify DNA fragments from standard or 
low-melt agarose gels in TAE or TBE buffer.  
• Isopropanol (100%) and a heating block or water bath at 50°C are required 
• All centrifugation steps are carried out at >10,000 x g (13,000 rpm) in a 
conventional table-top microcentrifuge 
1. Excise the DNA fragment from the agarose gel with a clean, sharp scalpel. 
Minimize the size of the gel slice by removing extra agarose. Caution: 260 nm 
UV-light will damage your DNA immediately, 300 nm will damage your 
DNA rapidly, only 360 nm UV-light is recommended 
 54 
2. Place excised agarose gel slice in a sterile 1.5 ml E-tube. Determine gel mass by 
first pre-weighing the tube, and then re-weighing the tube with the excised gel 
slice 
3. Add 300 µl Binding Buffer for every 100 mg agarose gel slice to the E-tube 
4. Dissolve agarose gel slice in order to release the DNA:  
• Vortex the E-tube 15-30 seconds to resuspend the gel slice in the Binding 
Buffer 
• Incubate the suspension for 10 minute at 56°C 
• Vortex the tube briefly every 2-3 min during incubation 
5. After the agarose gel slice is completely dissolved: Add 150 µl isopropanol for 
every 100 mg agarose gel slice to the tube. Vortex thoroughly 
6. Insert one High Pure filter tube into one Collection tube. Pipette the entire contents 
of the E-tube into the upper reservoir of the filter tube. Caution: Do not exceed 700 
µl total volume. If mixture is > 700 µl, split the volume and use two separate filter 
tubes for each portion 
7. Centrifuge 30-60 seconds at maximum speed in a standard table top centrifuge at 
15-25° C 
8. Discard the flow-through solution and reconnect filter tube with the same 
collection tube 
9. Add 500 µl Wash Buffer to the upper reservoir and centrifuge 1 minute at 
maximum speed (as above) 
10. •  Discard the flow-through solution 
• Combine filter tube with the same collection tube 
• Add 200 µl Wash Buffer  
• Centrifuge 1 minute at maximum speed 
Note: This second 200 µl wash step ensures optimal purity and complete removal 
of Wash Buffer from the glass fibers 
11. Discard the flow-through solution and collection tube and re-combine filter tube 
with a clean 1.5 ml E-tube 
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12. Add 50 µl Elution Buffer to the upper reservoir of the filter tube. Wait 3 min. 
Centrifuge 1 minute at maximum speed 
13. The microcentrifuge tube now contains the purified DNA     
 
 
Appendix 11 
Ligation  
Sir2 fragment (digested and purified): use 3 µl in 20 µl Σ (total volume) (replace with 
water in the negative control). 
pYES2 vector (digested and purified): use 2 µl in 20 µl Σ (total volume). 
for each ligation: 
 
1 µl DNA ligase (Note: the enzyme is added last!) 
10 µl 2 x ligation buffer 
up to 20 µl with H2O 
 
 pYES2+Sir2 
ligation 
pYES2 ligation 
(negative control) 
DNA fragment 3µl 0µl 
DNA vector 2µl 2µl 
buffer 10µl 10µl 
H2O 4µl 7µl 
Ligase 1µl 1µl 
Σ (total volume) 20 µl 20 µl 
 
The ligations are mixed well and incubated for exactly 5 min at room temperature. 
Put on ice or freeze afterwards. 
 56 
Appendix 12 
Figures 
 
Figure1: Human SirT1 PCR (left no.4 bands) and GAPDH (positive control) (right 
no.2 bands) 
 
 
Figure2: SirT1-TA plasmid restriction enzyme digestion by BamH1, Xbal1 and EcoR1 
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Figure 3 pYES2-Sir2 plasmid and pYES2 vector restriction enzyme digestion by 
EcoRI and XhoI  
 
Figure 4 pYES2-Sir2 plasmids restriction enzyme digestion, one group (upper) 
digested with EcoRI and XhoI, the other group (lower) digested with BamHI. 
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Appendix 13 
Yeast transformation 
In advance prepare sterile solutions and plates (the ones in bold types are you 
supposed to make): 
 
    Liquid YPD medium 
    10xTE buffer, pH 7.5 
    1 x TE buffer, pH 7.5 
    Sterile dd H2O 
50 % PEG  3350 
1 M lithium acetate (LiAC) (teratogenic!)  
    YPD plates 
    Liquid SD/-URA medium 
    SD/-URA plates 
SD-URA : 
0.77g/l   -ura do suppiement  
26.7g/l    SD base  
Fill up to 1L with dH2O, autoclave at 120°C. 
 
YPD :  
YPD  medium 50g  
Fill up to 1L with dH2O, autoclave at 120°C. 
  
N3 : 
Yeast extract      10g 
Bacto tryptone    20g 
Glycerol         20ml  
Agar            15 g 
Make 50mM phosphate buffer, calibrate PH to be 6.24 
Then dissolve them and fill up to 1000ml with 50mM phosphate buffer, autoclave at 
120°C. 
 
Remember to keep all things sterile, use sterile solutions, glassware, pipettes, 
toothpicks. Minimize exposure to open air. All waste must be collected and 
autoclaved! 
 
Day 1. 
 
1. Make yeast single colonies: Find the wild-type yeast strain (Y0) in the -80°C 
freezer (Merete will show you). Streak a tiny clump of Y0 culture onto a YPD 
plate using a sterile toothpick. Use a second sterile toothpick to streak 
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perpendicular to the first. Use a third sterile toothpick to make a zigzag streak 
from the second streak  
 
2. Incubate upside down in the 30 °C incubator for 2-3 days. 
 
Day 2, in the afternoon 
  
3. Using a sterile toothpick, pick a single large colony from the YPD plate and 
inoculate 20 ml liquid YPD in a sterile Erlenmeyer flask. Incubate at 30 °C in a 
shaking water bath with vigorous shaking (needs oxygen). Also incubate 10 ml 
of non-inoculated YPD medium (negative control). 
 
Day 3, as early as possible 
 
4. Using a 25 ml pipette transfer 12 ml of the overnight culture into a sterile 
Erlenmeyer flask containing 100 ml YPD medium. Incubate in the shaking 
water bath for 3 hours. 
 
5. Meanwhile prepare  
 
Fresh 1 x TE/LiAC:  10 x TE  100 µl 
       1 M LiAc, pH 7.5 100 µl 
       sterile ddH2O  800 µl 
       total   1000 µl 
 
 
 
Fresh 1xPEG/LiAc   10 x TE  200 µl 
       1 M LiAc, pH 7.5 200 µl 
       50 % PEG 3350 1600 µl 
       total   2000 µl 
    
 
6. Set a heating block to 95°C. Incubate the tube with heering/salmon testes 
carrier DNA for 5 min. Put in an ice bath (denaturation of DNA). 
 
7. Using 25 ml pipettes transfer 45 ml of your cell culture to each of two sterile 50 
ml centrifuge tubes. Put both in one Hereaus “centrifuge adaptor”, put the 
adaptor on the weight and set “tara”. Make a counterbalance using a second 
“centrifuge adaptor” with two 50 ml centrifuge tubes in which you fill water 
until the scale on the weight reaches 0 (+/- 0.05 g). Remember to include the 
weight of the caps! Put the two adaptors in the Hereaus centrifuge so there is 
complete symmetry. Centrifuge cells down at 3200 rpm at room temperature 
for 5 min.  
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8. Discard the supernatant (into a flask for autoclaving). Add 10 ml of sterile 
water to each tube, vortex to resuspend cell pellets, collect in one tube. 
 
9. Place the tube in the Hereaus centrifuge opposite a counterweight tube of 
similar weight. Centrifuge cells down at 3200 rpm at room temperature for 5 
min. 
 
10. Decant supernatant (into a flask for autoclaving). Resuspend the cell pellet in 
0.5 ml of the freshly prepared sterile 1xTE/LiAc. 
 
11. Mark three Eppendorph tubes with S, P or C  
 
Add 0.1 µg of your Sir2-pYES2 construct into S (Sir2) 
Add 0.1 µg of the empty pYES vector into P (Plasmid)  
Add a similar volume of sterile water into C (Control). 
 
12. To each tube add 10 µl denatured heering/salmon testes carrier DNA (10 mg/ml) 
100 µl of your yeast cell solution and 600 µl sterile freshly prepared PEG/LiAc 
solution. Vortex to mix. 
 
13. Incubate tubes for 30 min in the 30 °C incubator. Invert a couple of times 
during incubation. 
 
14. Meanwile set a second heating block to 42 °C.  
 
15. In the fume hood add 70 µl DMSO to each tube. Mix gently by inversion. 
 
16. Heat shock in the 42 °C heating block for 15 min. Invert 2-3 times during 
incubation. 
 
17. Chill cells on ice. 
 
18. Pellet cells by centrifugation in an Ole Dick centrifuge, 14 K in 5 sec. 
 
19. Remove the supernatant with a pipette. Resuspend pellet in 500 µl 1 x TE 
buffer. 
 
20. Plate 100 µl of each transformation mixture on a marked SD/-URA plate 
(eventually 10 µl on one half and 100 µl on the other half of the plate. When the 
transformation mixture has soaked down into the plates, incubate them upside 
down for 1-2 days at 30 °C. Also plate 100 µl of the C-transformation on aYPD 
plate (to check survival). 
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Day 4 
 
21. Count colonies on each plate. If the C-plates are without colonies, pick eight 
colonies from the S- and P-plate and streak them onto new SD/-URA plates to 
produce single colonies. (Divide a SD/-URA plate into eight “cake slices” and 
use three toothpicks to produce single colonies from each) 
 
Day 5 
 
22. For three “S” and three “P” colonies inoculate 5 ml liquid SD/-URA in tubes to 
make glycerol stocks. Incubate at 30 °C in a shaking water bath. Remember 
negative control. 
23. Mix 600 µl overnight culture with 300 µl sterile glycerol in marked cryotubes. 
Store at -80°C. 
In here, added 375µl the concentration of 80% glycerol to 625µl overnight 
culture, as to get the concentration of 30% glycerol in mixtures.  
24. make one YPD plate with YO ,SIR2- and MSH1- strains and another one N3 
plate with YO ,SIR2- and MSH1- strains, incubate them at 30 °C for around 
5days. These plates will be used in erythromycin prospective assay. 
25. make one YPD plate with YO ,SIR2- and ogg- strains and two SD-URA plates 
with three“S” and three “P”strains which it was been stored at -80°C, incubate 
them at 30 °C for around few days. These plates will be used in erythromycin 
real assay. 
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Appendix 14 
Data of pilot assay 
Table 1: cell density per 200µl cultures, it calculates from OD 600.  Three wild type 
(YO) cultures and three deletions Sir2 strain (Sir2-) cultures. 
 
 
 
 
 
 
 
 
 
 
 
Dilute YO  1 YO    2 YO  3 SIR2-  1 SIR2-  12 SIR2-  3 
10 (OD600 ) 2.704 2.531 2.612 2.389 2.031 2.460 
100(OD600) 
Density 
1.286 
3.122*107/ml 
1.074 
1.215*107/ml 
1.196 
2.673*107/ml 
0.939 
1.147*107/ml 
0.452 
0.620*107/ml 
1.046 
2.0322*107/ml 
103(OD600) 
Per1ml 
Per200µl 
0.225 
0.287*107/ml 
0.0574*107 
0.159 
0.2014*107/ml 
0.04028*107 
0.206 
0.262*107/ml 
0.0524*107 
0.125 
0.159*107/ml 
0.0318*107 
0.04 
0.053*107/ml 
0.0106*107 
0.164 
0.2091*107/ml 
0.04182*107 
104(OD600) 
Per200µl 
0.0574*106 0.04028*106 0.0524*106 0.0318*106 0.0106*106 0.04182*106 
105(OD600) 
Per200µl 
0.0574*105 0.04028*105 0.0524*105 0.0318*105 0.0106*105 0.04182*105 
106(OD600) 
Per200µl 
574 402 524 318 106 418 
107(OD600) 
Per200µl 
57 40 52 32 10 42 
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Appendix 15 
Data of erythromycin assay (real assay) 
Table 2: cell density per 200µl cultures, it calculates from OD 600.  Three empty 
pYES2 strain cultures and three Sir2-pYES2 strain cultures. 
 
Dilute 
empty pYES2  
1 
empty pYES2  
2 
Empty pYES2  
3 
Sir2-pYES2  
1 
Sir2-pYES2 
2 
Sir2-pYES2 
3 
10 (OD600 ) 3.00 3 3 3 3 3 
100(OD600) 1.763 1.784 1.791 1.677 1.851 1.867 
103(OD600) 
Density 
Per1ml 
0.391 
0.515*107/ml 
0.395 
0.521*107/ml 
0.452 
0.620*107/ml 
0.339 
0.438*107/ml 
0.439 
0.592*107/ml 
0.443 
0.604*107/ml 
104(OD600) 
Density 
Per200µl 
0.043 
0.0114*107 
0.041 
0.0108*107 
0.048 
0.01248*107 
0.045 
0.012*107 
0.046 
0.0122*107 
0.049 
0.01274*107 
105(OD600) 
Density 
Per200µl 
0.0114*106 0.0108*106 0.01248*106 0.012*106 0.0122*106 0.01274*106 
106(OD600) 
Density 
Per200µl 
0.0114*105 0.0108*105 0.01248*105 0.012*105 0.0122*105 0.01274*105 
107(OD600) 
Density 
Per200µl 
114 108 125   120 122 127 
108(OD600) 
Density 
Per200µl 
11 10 12 12 12 13 
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Table 3: cell density per 200µl cultures, it calculates from OD 600.  Three deletion 
OGG train (Ogg1-) cultures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dilute Ogg1-  1 Ogg1-   2 Ogg1-  3 
10 (OD600 ) 3.00 3 3 
100(OD600) 2.005 2.135 2.277 
103(OD600) 
Density Per1ml 
0.528 
0.744*107/ml 
0.662 
0.969*107/ml 
0.672 
0.986*107/ml 
 
104(OD600) 
Density Per200µl 
0.056 
0.0146*107 
0.075 
0.01928*107 
0.127 
0.0324*107 
105(OD600) 
Density Per200µl 
0.0146*106 0.01928*106 0.0324*106 
106(OD600) 
Density Per200µl 
0.0146*105 0.01928*105 0.0324*105 
107(OD600) 
Density 
Per200µl 
146 192 324 
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Table 4: cell density per 200µl cultures, it calculates from OD 600. Three wild type  
(YO) strain cultures and three deletion Sir 2 (Sir2-) strain cultures 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dilute YO  1 YO    2 YO  3 SIR2-  1 SIR2-  12 SIR2-  3 
10 (OD600 ) 3.00 3 3 3 3 3 
100(OD600) 2.018 2.384 2.186 2.085 2.201 1.844 
103(OD600) 
Density 
Per1ml 
0.589 
0.862*107/ml 
0.792 
1.243*107/ml 
0.683 
1.004*107/ml 
0.621 
0.901*107/ml 
0.650 
0.950*107/ml 
0.450 
0.617*107/ml 
104(OD600) 
Density 
Per200µl 
0.038 
0.01*107 
0.084 
0.0216*107 
0.079 
0.0204*107 
0.062 
0.0162*107 
0.074 
0.01902*107 
0.044 
0.01166*107 
105(OD600) 
Density 
Per200µl 
0.01*106 0.0216*106 0.0204*106 0.0162*106 0.01902*106 0.01166*106 
106(OD600) 
Density 
Per200µl 
0.01*105 0.0216*105 0.0204*105 0.0162*105 0.01902*105 0.01166*105 
107(OD600) 
Density 
Per200µl 
100 216 204 162 190 117 
108(OD600) 
Density 
Per200µl 
10 21 20 16 19 11 
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Appendix 16 
Protokol 1:Celletæthed målt med OD660 
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